SIGNIFICANT ACCOUNTING POLICIES AND OTHER RISKS AND UNCERTAINTIES (Details Narrative) $ / shares in Units, shares in Millions |
1 Months Ended | 12 Months Ended | |||||
|---|---|---|---|---|---|---|---|
|
Mar. 31, 2026
USD ($)
|
Nov. 04, 2025
USD ($)
|
Jan. 31, 2026
USD ($)
$ / shares
shares
|
Mar. 31, 2026
USD ($)
|
Mar. 31, 2025
USD ($)
|
Mar. 31, 2026
AUD ($)
|
Mar. 31, 2026
EUR (€)
|
|
| Product Information [Line Items] | |||||||
| Net cash used in operating activities | $ 18,144,000 | $ 38,218,000 | |||||
| Accumulated deficit | $ 319,571,000 | 319,571,000 | 286,322,000 | ||||
| Cash equivalents and marketable securities | 11,600,000 | 11,600,000 | |||||
| Cash deposit | 3,400,000 | 3,400,000 | |||||
| Allowance for credit losses | 100,000 | $ 100,000 | 0 | ||||
| Derivative liability description | The derivative liability represents an embedded redemption feature (embedded put option) that meets the criteria to be classified as a derivative and is bifurcated from the Note (see Note 9). On any trading day during which the Registration Statement (Note 4) remains effective and the Note remains outstanding and (i) any trading price of the Company’s common stock is at least 5% greater than the current Nasdaq minimum price as defined under Nasdaq Rule 5635(d) (the “Nasdaq Minimum Price”) or (ii) the total dollar trading volume has reached $750,000.00, Streeterville may elect to purchase shares of common stock up to the Beneficial Ownership Limitation at a purchase price equal to 85% of the Nasdaq Minimum Price, subject to a floor of $0.39 per share. The aggregate purchase price for these shares shall be offset by an equal amount outstanding under the Note. | ||||||
| Fair value of issued common stock | 3,300,000 | $ 3,300,000 | |||||
| Fair value of the derivative liability | 2,200,000 | 2,200,000 | |||||
| Restricted cash | $ 5,600,000 | $ 5,600,000 | 200,000 | ||||
| Proceeds from issuance of secured promissory note | $ 5,400,000 | ||||||
| Concentration risk benchmark description | As of March 31, 2026, the Company had greater than $250,000 at United States financial institutions, less than A$250,000 at Australian financial institutions, greater than €100,000 at Irish financial institutions and also has funds on deposit in Israel. | ||||||
| Number of repotable segments | true | ||||||
| Obsolescence reserves | $ 400,000 | $ 400,000 | 200,000 | ||||
| Accumulated other comprehensive income | $ 200,000 | $ 200,000 | 100,000 | ||||
| Other asset impairment charges | $ 500,000 | ||||||
| Beyond Cancer Ltd [Member] | |||||||
| Product Information [Line Items] | |||||||
| Non-controlling owners interest | 20.00% | 20.00% | 20.00% | 20.00% | |||
| NeuroNos Ltd [Member] | |||||||
| Product Information [Line Items] | |||||||
| Non-controlling owners interest | 15.25% | 15.25% | 15.25% | 15.25% | |||
| Accounts Payable [Member] | Customer Concentration Risk [Member] | First Third Party Vendors [Member] | |||||||
| Product Information [Line Items] | |||||||
| Concentration percentage | 74.00% | ||||||
| Accounts Payable [Member] | Customer Concentration Risk [Member] | Second Third Party Vendors [Member] | |||||||
| Product Information [Line Items] | |||||||
| Concentration percentage | 18.00% | ||||||
| Accounts Payable [Member] | Customer Concentration Risk [Member] | Third Party Vendors [Member] | |||||||
| Product Information [Line Items] | |||||||
| Concentration percentage | 85.00% | ||||||
| Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customers One [Member] | |||||||
| Product Information [Line Items] | |||||||
| Concentration percentage | 11.00% | 16.00% | |||||
| Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customers Two [Member] | |||||||
| Product Information [Line Items] | |||||||
| Concentration percentage | 10.00% | 10.00% | |||||
| Australian Taxation Office [Member] | |||||||
| Product Information [Line Items] | |||||||
| Tax Rebate | $ 100,000 | $ 0.0 | |||||
| UNITED STATES | |||||||
| Product Information [Line Items] | |||||||
| Cash FDIC insured amount | $ 250,000 | 250,000 | |||||
| AUSTRALIA | |||||||
| Product Information [Line Items] | |||||||
| Cash FDIC insured amount | $ 250,000 | ||||||
| BERMUDA | |||||||
| Product Information [Line Items] | |||||||
| Cash FDIC insured amount | $ 25,000 | $ 25,000 | |||||
| IRELAND | |||||||
| Product Information [Line Items] | |||||||
| Cash FDIC insured amount | € | € 100,000 | ||||||
| CYPRUS | |||||||
| Product Information [Line Items] | |||||||
| Cash FDIC insured amount | € | € 100,000 | ||||||
| Streeterville Capital LLC [Member] | |||||||
| Product Information [Line Items] | |||||||
| Purchase of common stock, shares | shares | 1.6 | ||||||
| Share price | $ / shares | $ 0.73 | ||||||
| Debt amount | $ 1,200,000 | ||||||